Screener
Eton Pharmaceuticals, Inc. ETON Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Eton Pharmaceuticals, Inc.’s reported figures.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | For the three months ended / March 31, 2026 | For the three months ended / March 31, 2025 |
|---|---|---|
| Licensing revenue | — | 825 |
| Product sales and royalties | 9,531 | 6,596 |
| Total cost of sales | 9,531 | 7,421 |
| Gross profit | 14,735 | 9,861 |
| Operating expenses: | ||
| Research and development | 1,875 | 1,161 |
| General and administrative | 10,446 | 9,170 |
| Total operating expenses | 12,321 | 10,331 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s gross profit?
- Eton Pharmaceuticals, Inc. (ETON) reported gross profit of $14.74M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s gross profit changed year-over-year?
- Eton Pharmaceuticals, Inc.'s gross profit increased by 49.4% year-over-year, from $9.86M to $14.74M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s gross profit?
- Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s gross profit has grown at a 22.4% compound annual growth rate (CAGR), from $19.04M to $42.74M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Eton Pharmaceuticals, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude